ISSN:
1432-1440
Keywords:
Medullary thyroid carcinoma
;
RET proto-oncogene
;
Presymptomatic genetic screening
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Medullary thyroid carcinoma occurs sporadically or as a part of the inherited cancer syndrome multiple endocrine neoplasia (MEN) type 2. The MEN 2 gene has been identified as the RET proto-oncogene on chromosome 10. In MEN 2A, RET mutations are detectable in one of five cysteine codons within exons 10 and 11 and in MEN 2B in codon 918 (exon 16). Direct DNA testing for RET proto-oncogene mutations is the method of first choice in presymptomatic screening of MEN 2 families. Gene carriers should be offered prophylactic thyroidectomy. The process of DNA analysis for RET proto-oncogene mutations is demonstrated in one family with hereditary medullary thyroid carcinoma. RET mutations were detectable in five of the nine family members at risk.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00189922
